Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LACTOSE INDIA   ACTAVIS
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-23
ACTAVIS
Dec-18
LACTOSE INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs9616,159-   
Low Rs3910,840-   
Sales per share (Unadj.) Rs52.33,963.8-  
Earnings per share (Unadj.) Rs1.0-1,276.8-  
Cash flow per share (Unadj.) Rs4.7417.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs32.216,349.0-  
Shares outstanding (eoy) m12.59332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.4 38.1%   
Avg P/E ratio x70.6-10.6 -667.8%  
P/CF ratio (eoy) x14.532.3 44.8%  
Price / Book Value ratio x2.10.8 254.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m8544,489,898 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1220-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m6581,318,372 0.0%  
Other income Rs m725,212 0.0%   
Total revenues Rs m6651,343,584 0.0%   
Gross profit Rs m11534,548 0.3%  
Depreciation Rs m47563,576 0.0%   
Interest Rs m6076,078 0.1%   
Profit before tax Rs m15-579,893 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m3-7,349 -0.0%   
Profit after tax Rs m12-424,648 -0.0%  
Gross profit margin %17.42.6 664.4%  
Effective tax rate %17.51.3 1,377.8%   
Net profit margin %1.8-32.2 -5.7%  
BALANCE SHEET DATA
Current assets Rs m375540,727 0.1%   
Current liabilities Rs m266478,345 0.1%   
Net working cap to sales %16.64.7 351.2%  
Current ratio x1.41.1 124.9%  
Inventory Days Days4620 232.6%  
Debtors Days Days69366 1,045.1%  
Net fixed assets Rs m643149,232 0.4%   
Share capital Rs m1260-   
"Free" reserves Rs m2800-   
Net worth Rs m4065,437,670 0.0%   
Long term debt Rs m3301,914,801 0.0%   
Total assets Rs m1,0188,500,316 0.0%  
Interest coverage x1.2-6.6 -18.8%   
Debt to equity ratio x0.80.4 231.3%  
Sales to assets ratio x0.60.2 416.8%   
Return on assets %7.1-4.1 -173.6%  
Return on equity %3.0-7.8 -38.2%  
Return on capital %10.2-4.8 -210.5%  
Exports to sales %00-   
Imports to sales %31.30-   
Net fx Rs m-1050-   
CASH FLOW
From Operations Rs m81471,005 0.0%  
From Investments Rs m-10258,756 -0.0%  
From Financial Activity Rs m-84-808,385 0.0%  
Net Cashflow Rs m-13-78,232 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare LACTOSE INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare LACTOSE INDIA With: SANJIVANI PA  NATCO PHARMA  ISHITA DRUGS  WANBURY  TTK HEALTHCARE  



Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.